Genetic trickery deployed by malaria to escape immune system attack revealed

Image
ANI Washington
Last Updated : Feb 26 2015 | 12:35 PM IST

A team of scientists has revealed that malaria plays hide-and-seek with human immune system by using long noncoding RNA to switch genes.

Researchers at the Hebrew University of Jerusalem have revealed the genetic trickery that this deadly Plasmodium falciparum parasite deploys to escape attack by the human immune system.

The parasite is known to replicate within the circulating blood of infected individuals and modify the surface of infected red blood cells. Its virulence comes from its impressive ability to hide from the immune system by selectively changing which surface proteins it displays.

This sophisticated game of hide-and-seek, which involves continually alternating the foreign molecules, called antigens that can trigger an immune response, is called antigenic variation.

Previous research has shown that the antigens the parasite selectively displays are encoded by members of a gene family named var. The parasite tightly regulates the expression of these var genes so that only one is expressed at any given time, while the rest of the family is maintained silent.

This study found that at the precise moment in the cell cycle when a specific var gene is active, corresponding RNA molecules (of a type called long noncoding RNA) are present, which incorporate themselves into DNA structures, and determine how the parasite selects a single gene for expression while the rest of the family is kept silent.

Researcher Ron Dzikowski said that they believe this breakthrough has exposed the tip of the iceberg in understanding how the deadliest malaria parasite regulates the selective expression of its genes, enabling it to evade the immune system.

Dzikowski added that understanding the mechanisms by which the parasite evades immunity takes them closer to finding ways to either block this ability, or force the parasite to expose its entire antigenic repertoire and thus allow the human immune system to overcome the disease. Such findings can help pave the way for development of new therapies and vaccines for malaria.

The study appears in the Proceedings of the National Academy of Sciences.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Feb 26 2015 | 12:24 PM IST

Next Story